Frexalimab – Talk Bio

Actionable Insights Powered by AI

Sanofi’s Frexalimab Shows Promise in Multiple Sclerosis with Positive Phase 2 Results

6 months ago talkbio0Tagged Antibodies, CD40 Ligand, Frexalimab, Multiple Sclerosis, Phase 2 trial, sanofi

Sanofi, Frexalimab, Multiple Sclerosis, Phase 2 Trial, CD40L Antibody